Augmented glucose dependency of autoreactive B cells provides a treatment target forlupus
J. J. Wilson, J. Wei, A. R. Daamen…·C.-H. Chang
This study identifies glycolysis-dependent autoreactive B cells as key mediators of lupus and shows that targeting them with 2DG or BCMA-specific CAR T-cells improves disease outcomes.